Clinical Trials Logo

Progressive IgA Nephropathy clinical trials

View clinical trials related to Progressive IgA Nephropathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT02282930 Completed - Proteinuria Clinical Trials

Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Start date: March 2015
Phase: Phase 3
Study type: Interventional

This study is designed to answer whether patients with progressive IgA nephropathy, who receive Acthar (ACTH) gel injection at a dose of 80 units subcutaneously twice weekly for 6 months is effective in inducing improvement in proteinuria and renal function.